Stock listing
TSX:VBV VBI Vaccines Inc. Stock
Follow VBI Vaccines Inc. into a list and get an email when it puts out news.
Delisted TSX:VBV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- TSX:VBV
- Asset type
- Stock
- Exchange
- TSX
- Currency
- CAD
VBI Vaccines Inc. on 6ix
- Decks
- 26 decks · latest Apr 3, 2024
Where VBI Vaccines Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:VBV · This page · Delisted | TSX | Canada | CAD |
| NASDAQ:VBIV · Delisted | NASDAQ | United States | USD |
| NASDAQ:VBIVQ · Delisted | NASDAQ | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| World Vaccine Congress 2024 | Conference | 11 slides | Apr 3, 2024 |
| Investor Presentation (February 2023) | Investor deck | 41 slides | Feb 28, 2023 |
| Hepatitis B Portfolio Fireside Chat led by Raymond James (February 2023) | Conference | 29 slides | Feb 28, 2023 |
| Investor Presentation (December 2022) | Investor deck | 37 slides | Dec 27, 2022 |
| Corporate Update (September 2021) | Corporate update | 11 slides | Sep 29, 2021 |
| Technical Presentation (November 2020) | Technical | 7 slides | Nov 19, 2020 |
| Corporate Update (November 2020) | Corporate update | 8 slides | Nov 18, 2020 |
| Technical Presentation (August 2020) | Technical | 9 slides | Aug 26, 2020 |
| Technical Presentation (June 2020) | Technical | 7 slides | Jun 22, 2020 |
| Canaccord Genuity 39th Annual Growth Conference (August 2019) | Conference | 11 slides | Aug 8, 2019 |
All 26 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Linda Bain Other companies: Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); Autolus Therapeutics plc (Chair of the Audit Committee, Member of the Nominating and Governance Committee · Since at least Mar 18, 2026); Arvinas, Inc. (Director · Since at least Jun 10, 2020); Codiak BioSciences Inc (Chief Financial Officer · Oct 13, 2020 – Mar 28, 2023 · Past); Adverum Biotechnologies Inc (Chief Financial Officer · Jul 30, 2014 – Aug 21, 2015 · Past); Bluebird bio Inc (VP, Fin. & Business Operations · Jun 18, 2013 – Feb 26, 2014 · Past) | Director · Jul 1, 2021 – Jan 27, 2022 · Past |
| Steven Gillis Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); Metsera, Inc. (Director · Since at least Nov 13, 2025); Codiak BioSciences Inc (Director · Oct 13, 2020 – Feb 16, 2023 · Past); Q32 Bio Inc. (Director · Jun 6, 2019 – Jun 14, 2023 · Past); Pulmatrix, Inc. (Director · May 16, 2019 – Aug 28, 2020 · Past) | Director · Jun 14, 2019 – Jul 27, 2023 · Past |
| Tomer Kariv Other companies: Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); 89bio Inc (Director · Nov 8, 2019 – Nov 11, 2019 · Past); LogicBio Therapeutics Inc (Director · Oct 18, 2018 – Dec 19, 2019 · Past); Arno Therapeutics Inc (Director · Jan 12, 2016 – Sep 8, 2016 · Past) | Director · Jan 23, 2018 – Jan 31, 2019 · Past |
| Scott Requadt Other companies: ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Tourmaline Bio Inc. (Chief Executive Officer, Director · May 6, 2021 – Feb 1, 2023 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 25, 2018 · Past) | Director · Dec 31, 2016 – Jan 31, 2019 · Past |
| Christopher McNulty Other companies: InVivo Therapeutics Holdings Corp (Chief Financial Officer · Mar 29, 2017 – Mar 29, 2017 · Past) | CFO and Head of BD, Director · Aug 14, 2018 – Jan 26, 2023 · Past |
| Jeff Baxter Other companies: Niagen Bioscience, Inc. (Director · Apr 16, 2015 – Jun 17, 2021 · Past) | CEO, President, Director · Jul 25, 2014 – Jul 27, 2023 · Past |
| Sam Chawla Other companies: Tigo Energy, Inc. (Director · Aug 5, 2021 – Aug 10, 2021 · Past) | Director · Oct 30, 2017 – Oct 30, 2017 · Past |
| Blaine H McKee | Director · Jan 26, 2023 – Jul 27, 2023 · Past |
| Damian Braga | Director · Jan 27, 2021 – Jul 27, 2023 · Past |
| David Evander Anderson | Chief Scientific Officer · Jul 25, 2014 – Jul 27, 2023 · Past |
All 16 people
| Person | Seat |
|---|---|
| Egidio Nascimento | Chief Financial Officer · Jul 25, 2014 – Mar 30, 2017 · Past |
| Francisco Diaz-Mitoma | Chief Medical Officer · Jun 20, 2019 – Jul 27, 2023 · Past |
| Joanne Cordeiro | Director · Apr 15, 2019 – Jul 27, 2023 · Past |
| John Robert Dillman | Chief Commercial Officer · Jul 7, 2022 – Jul 27, 2023 · Past |
| Marc Kirchmeier | VP, Vaccine Form Development · Jul 25, 2014 – Jul 30, 2015 · Past |
| Michel DeWilde | Director · Jul 25, 2014 – Jul 27, 2023 · Past |
Log in to ask 6ix AI your own questions about VBI Vaccines Inc.